Guidance

DTaP/IPV/Hib booster: patient group direction (PGD) template

PGD template for administering DTaP/IPV/Hib as a pre-school booster following national recommendations, to optimise use of vaccine supplies.

• From: Public Health England
• Published: 31 July 2017
• Last updated: 31 July 2019 — See all updates

This publication was withdrawn on 30 August 2019

This PGD has been withdrawn because it expired on 31 August 2019. Please use the updated Hexavalent vaccine, DTaP/IPV/Hib/HepB (Infanrix®-hexa) PGD template.

Documents

[Withdrawn] DTaP/IPV/Hib Booster: patient group direction (PGD) template

Ref: PHE gateway number 2017178

MS Word Document, 125 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of DTaP/IPV/Hib as a pre-school booster. This follows the introduction of hexavalent vaccine into the routine childhood immunisation programme, in accordance with national recommendations to optimise use of national vaccine supplies.

It is valid from 12 September 2017 to 31 August 2019.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 31 July 2017
Last updated 31 July 2019 + show all updates

1. 31 July 2019

   Reinstated PGD template which was withdrawn in error before its expiry on 31 August 2019.

2. 31 July 2017

   First published.